Published in Exp Clin Psychopharmacol on February 01, 2007
Gender differences in craving and cue reactivity to smoking and negative affect/stress cues. Am J Addict (2012) 1.25
Counterbalancing in smoking cue research: a critical analysis. Nicotine Tob Res (2010) 1.19
Neurobiological mechanisms involved in nicotine dependence and reward: participation of the endogenous opioid system. Neurosci Biobehav Rev (2010) 1.15
Effects of smoking abstinence, smoking cues and nicotine replacement in smokers with schizophrenia and controls. Nicotine Tob Res (2008) 1.15
Effects of repeated days of smoking cue exposure on urge to smoke and physiological reactivity. Addict Behav (2007) 0.99
Pharmacological effects of naltrexone and intravenous alcohol on craving for cigarettes among light smokers: a pilot study. Psychopharmacology (Berl) (2007) 0.98
Constitutional mechanisms of vulnerability and resilience to nicotine dependence. Mol Psychiatry (2009) 0.96
Dissociable effect of acute varenicline on tonic versus cue-provoked craving in non-treatment-motivated heavy smokers. Drug Alcohol Depend (2012) 0.85
Opioid antagonists for smoking cessation. Cochrane Database Syst Rev (2013) 0.84
Effects of divalproex on smoking cue reactivity and cessation outcomes among smokers achieving initial abstinence. Exp Clin Psychopharmacol (2012) 0.83
Smoking cue reactivity in adult smokers with and without depression: a pilot study. Am J Addict (2012) 0.82
Cue-elicited increases in incentive salience for marijuana: Craving, demand, and attentional bias. Drug Alcohol Depend (2016) 0.81
Systematic review and meta-analysis of opioid antagonists for smoking cessation. BMJ Open (2014) 0.80
Transdermal nicotine during cue reactivity in adult smokers with and without anxiety disorders. Psychol Addict Behav (2012) 0.80
Menstrual cycle phase effects in the gender dimorphic stress cue reactivity of smokers. Nicotine Tob Res (2014) 0.80
Effects of the opioid receptor antagonist naltrexone on smoking and related behaviors in smokers preparing to quit: a randomized controlled trial. Addiction (2013) 0.78
Timing of nicotine lozenge administration to minimize trigger induced craving and withdrawal symptoms. Addict Behav (2017) 0.78
A Double-Blind Randomized Placebo-Controlled Trial of Oral Naltrexone for Heavy Drinking Smokers Seeking Smoking Cessation Treatment. Alcohol Clin Exp Res (2017) 0.75
The opioid receptors as targets for drug abuse medication. Br J Pharmacol (2015) 0.75
The effectiveness of naltrexone combined with current smoking cessation medication to attenuate post smoking cessation weight gain: a literature review. J Pharm Policy Pract (2017) 0.75
Endogenous opioid system: a promising target for future smoking cessation medications. Psychopharmacology (Berl) (2017) 0.75
Topiramate for treating alcohol dependence: a randomized controlled trial. JAMA (2007) 6.81
A randomized clinical trial of a brief motivational intervention for alcohol-positive adolescents treated in an emergency department. J Pediatr (2004) 3.62
Genetic triple dissociation reveals multiple roles for dopamine in reinforcement learning. Proc Natl Acad Sci U S A (2007) 3.33
Efficacy of counselor vs. computer-delivered intervention with mandated college students. Addict Behav (2007) 3.08
Validation of the timeline follow-back in the assessment of adolescent smoking. Drug Alcohol Depend (2005) 2.37
Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study. Arch Gen Psychiatry (2007) 2.28
Alcohol demand, delayed reward discounting, and craving in relation to drinking and alcohol use disorders. J Abnorm Psychol (2010) 2.27
A polymorphism of the mu-opioid receptor gene (OPRM1) and sensitivity to the effects of alcohol in humans. Alcohol Clin Exp Res (2004) 2.25
Brief alcohol interventions with mandated or adjudicated college students. Alcohol Clin Exp Res (2004) 2.10
"I'll never drink like that again": characteristics of alcohol-related incidents and predictors of motivation to change in college students. J Stud Alcohol (2006) 1.87
Alcohol use disorders identification test: factor structure in an adolescent emergency department sample. Alcohol Clin Exp Res (2002) 1.85
Motivational enhancement and other brief interventions for adolescent substance abuse: foundations, applications and evaluations. Addiction (2004) 1.82
Exposure to the taste of alcohol elicits activation of the mesocorticolimbic neurocircuitry. Neuropsychopharmacology (2007) 1.76
Motivational enhancement and coping skills training for cocaine abusers: effects on substance use outcomes. Addiction (2004) 1.68
Randomized clinical trial examining the incremental efficacy of a 90-minute motivational alcohol intervention as an adjunct to standard batterer intervention for men. Addiction (2013) 1.68
Marijuana craving in the brain. Proc Natl Acad Sci U S A (2009) 1.62
Pharmacotherapy of dual substance abuse and dependence. CNS Drugs (2007) 1.61
Dopaminergic genes predict individual differences in susceptibility to confirmation bias. J Neurosci (2011) 1.58
Stepped care for mandated college students: a pilot study. Am J Addict (2007) 1.58
The Marijuana Ladder: measuring motivation to change marijuana use in incarcerated adolescents. Drug Alcohol Depend (2005) 1.53
Moderators of naltrexone's effects on drinking, urge, and alcohol effects in non-treatment-seeking heavy drinkers in the natural environment. Alcohol Clin Exp Res (2007) 1.53
Effects of topiramate on urge to drink and the subjective effects of alcohol: a preliminary laboratory study. Alcohol Clin Exp Res (2008) 1.51
Peer enhancement of a brief motivational intervention with mandated college students. Psychol Addict Behav (2007) 1.47
The mixed evidence for brief intervention in emergency departments, trauma care centers, and inpatient hospital settings: what should we do? Alcohol Clin Exp Res (2010) 1.47
Brief motivational intervention for adolescent smokers in medical settings. Addict Behav (2004) 1.44
Ethanol in formularies of US teaching hospitals. JAMA (2003) 1.44
A transdisciplinary model integrating genetic, physiological, and psychological correlates of voluntary exercise. Health Psychol (2007) 1.43
Cigarette smoking topography in smokers with schizophrenia and matched non-psychiatric controls. Drug Alcohol Depend (2005) 1.43
Differential neural response to alcohol priming and alcohol taste cues is associated with DRD4 VNTR and OPRM1 genotypes. Alcohol Clin Exp Res (2008) 1.43
Identifying neurobiological phenotypes associated with alcohol use disorder severity. Neuropsychopharmacology (2011) 1.41
Predictors of motivation to change after medical treatment for drinking-related events in adolescents. Psychol Addict Behav (2002) 1.40
Subjective responses to alcohol consumption as endophenotypes: advancing behavioral genetics in etiological and treatment models of alcoholism. Subst Use Misuse (2010) 1.39
Polymorphisms of the mu-opioid receptor and dopamine D4 receptor genes and subjective responses to alcohol in the natural environment. J Abnorm Psychol (2010) 1.37
Addressing alcohol use and problems in mandated college students: a randomized clinical trial using stepped care. J Consult Clin Psychol (2012) 1.36
Perceived barriers to quitting smoking among alcohol dependent patients in treatment. J Subst Abuse Treat (2003) 1.36
Improvement of physical health and quality of life of alcohol-dependent individuals with topiramate treatment: US multisite randomized controlled trial. Arch Intern Med (2008) 1.34
DRD4 VNTR polymorphism is associated with transient fMRI-BOLD responses to smoking cues. Psychopharmacology (Berl) (2007) 1.34
Behavioral economic analysis of cue-elicited craving for alcohol. Addiction (2010) 1.33
Addressing heavy drinking in smoking cessation treatment: a randomized clinical trial. J Consult Clin Psychol (2008) 1.33
Olanzapine reduces craving for alcohol: a DRD4 VNTR polymorphism by pharmacotherapy interaction. Neuropsychopharmacology (2003) 1.29
Catching the alcohol buzz: an examination of the latent factor structure of subjective intoxication. Alcohol Clin Exp Res (2009) 1.28
Enhancing Substance Abuse Treatment Engagement in Incarcerated Adolescents. Psychol Serv (2006) 1.27
Treating adolescents together or individually? Issues in adolescent substance abuse interventions. Alcohol Clin Exp Res (2002) 1.26
The DRD4 VNTR polymorphism moderates craving after alcohol consumption. Health Psychol (2002) 1.26
Profiles of college students mandated to alcohol intervention. J Stud Alcohol Drugs (2008) 1.25
Moderators and mediators of two brief interventions for alcohol in the emergency department. Addiction (2010) 1.24
Genetic moderators of naltrexone's effects on alcohol cue reactivity. Alcohol Clin Exp Res (2006) 1.24
Individual and family motivational interventions for alcohol-positive adolescents treated in an emergency department: results of a randomized clinical trial. Arch Pediatr Adolesc Med (2011) 1.24
Correlates of motivation to quit smoking among alcohol dependent patients in residential treatment. Drug Alcohol Depend (2005) 1.21
Response distortion in adolescents who smoke: a pilot study. J Drug Educ (2002) 1.21
Balanced placebo design with marijuana: pharmacological and expectancy effects on impulsivity and risk taking. Psychopharmacology (Berl) (2012) 1.21
Do genetic and individual risk factors moderate the efficacy of motivational enhancement therapy? Drinking outcomes with an emerging adult sample. Addict Biol (2009) 1.19
Individual and additive effects of the CNR1 and FAAH genes on brain response to marijuana cues. Neuropsychopharmacology (2009) 1.19
The route to change: within-session predictors of change plan completion in a motivational interview. J Subst Abuse Treat (2010) 1.18
Typologies of alcohol dependence. From Jellinek to genetics and beyond. Neuropsychol Rev (2009) 1.16
Cost-effectiveness of a motivational intervention for alcohol-involved youth in a hospital emergency department. J Stud Alcohol Drugs (2010) 1.16
Effects of smoking abstinence, smoking cues and nicotine replacement in smokers with schizophrenia and controls. Nicotine Tob Res (2008) 1.15
Cue reactivity in adolescents: measurement of separate approach and avoidance reactions. J Stud Alcohol (2005) 1.14
The dopamine D Receptor (DRD4) gene exon III polymorphism, problematic alcohol use and novelty seeking: direct and mediated genetic effects. Addict Biol (2008) 1.14
Marijuana withdrawal and craving: influence of the cannabinoid receptor 1 (CNR1) and fatty acid amide hydrolase (FAAH) genes. Addiction (2008) 1.13
Current and promising pharmacotherapies, and novel research target areas in the treatment of alcohol dependence: a review. Curr Pharm Des (2011) 1.13
Associations between cannabinoid receptor-1 (CNR1) variation and hippocampus and amygdala volumes in heavy cannabis users. Neuropsychopharmacology (2012) 1.13
Cocaine craving as a predictor of treatment attrition and outcomes after residential treatment for cocaine dependence. J Stud Alcohol Drugs (2007) 1.12
Subjective response to alcohol among alcohol-dependent individuals: effects of the μ-opioid receptor (OPRM1) gene and alcoholism severity. Alcohol Clin Exp Res (2012) 1.12
Ghrelin system in alcohol-dependent subjects: role of plasma ghrelin levels in alcohol drinking and craving. Addict Biol (2011) 1.11
Daily college student drinking patterns across the first year of college. J Stud Alcohol Drugs (2012) 1.10
Role of feeding-related pathways in alcohol dependence: A focus on sweet preference, NPY, and ghrelin. Alcohol Clin Exp Res (2010) 1.09
The commitment to quitting smoking scale: initial validation in a smoking cessation trial for heavy social drinkers. Addict Behav (2007) 1.09
Acute Effects of Marijuana Smoking on Negative and Positive Affect. J Cogn Psychother (2011) 1.08
Subjective and physiological responses to smoking cues in smokers with schizophrenia. Nicotine Tob Res (2005) 1.08
The Smoking Effects Questionnaire for adult populations. Development and psychometric properties. Addict Behav (2003) 1.07
The role of marijuana use in brief motivational intervention with young adult drinkers treated in an emergency department. J Stud Alcohol Drugs (2009) 1.07
Separate and combined effects of very low nicotine cigarettes and nicotine replacement in smokers with schizophrenia and controls. Nicotine Tob Res (2012) 1.06
Effectiveness of a marijuana expectancy manipulation: Piloting the balanced-placebo design for marijuana. Exp Clin Psychopharmacol (2009) 1.05
How psychosocial alcohol interventions work: a preliminary look at what FMRI can tell us. Alcohol Clin Exp Res (2011) 1.05
Motivational interviewing for incarcerated adolescents: effects of depressive symptoms on reducing alcohol and marijuana use after release. J Stud Alcohol Drugs (2011) 1.05
Association of the 5-HTT gene-linked promoter region (5-HTTLPR) polymorphism with psychiatric disorders: review of psychopathology and pharmacotherapy. Pharmgenomics Pers Med (2012) 1.04
Neural and behavioral mechanisms of impulsive choice in alcohol use disorder. Alcohol Clin Exp Res (2011) 1.04
Nicotine and other substance interaction expectancies questionnaire: relationship of expectancies to substance use. Addict Behav (2005) 1.04
Alcohol use and related harm among older adolescents treated in an emergency department: the importance of alcohol status and college status. J Stud Alcohol (2003) 1.04
Sensation seeking as a predictor of treatment compliance and smoking cessation treatment outcomes in heavy social drinkers. Pharmacol Biochem Behav (2009) 1.04
Rare copy number deletions predict individual variation in intelligence. PLoS One (2011) 1.04
Review of topiramate: an antiepileptic for the treatment of alcohol dependence. Curr Drug Abuse Rev (2009) 1.04
Effects of motivational interviewing for incarcerated adolescents on driving under the influence after release. Am J Addict (2006) 1.03
Tobacco and alcohol use as an explanation for the association between externalizing behavior and illicit drug use among delinquent adolescents. Prev Sci (2004) 1.03
What makes group MET work? A randomized controlled trial of college student drinkers in mandated alcohol diversion. Psychol Addict Behav (2009) 1.03
Current pharmacotherapies of alcoholism: a U.S. perspective. Am J Addict (2003) 1.03
Association between nicotine dependence severity, BOLD response to smoking cues, and functional connectivity. Neuropsychopharmacology (2013) 1.02
Variation in brain-derived neurotrophic factor (BDNF) gene is associated with symptoms of depression. J Affect Disord (2008) 1.02
Motivational interviewing with significant other participation: assessing therapeutic alliance and patient satisfaction and engagement. J Subst Abuse Treat (2010) 1.02
Urge-specific and lifestyle coping strategies of cocaine abusers: relationships to treatment outcomes. Drug Alcohol Depend (2005) 1.02
Effect of a significant other on client change talk in motivational interviewing. J Consult Clin Psychol (2012) 1.02
Effects of naltrexone on adolescent alcohol cue reactivity and sensitivity: an initial randomized trial. Addict Biol (2013) 1.02